Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

8.59
+0.07920.93%
Volume:251.36K
Turnover:2.18M
Market Cap:710.87M
PE:69.88
High:9.00
Open:9.00
Low:8.41
Close:8.51
52wk High:11.25
52wk Low:5.81
Shares:82.76M
Float Shares:47.16M
Volume Ratio:2.41
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1229
EPS(LYR):-0.5196
ROE:6.38%
ROA:4.13%
PB:4.28
PE(LYR):-16.53

Loading ...

Canaccord Genuity Keeps Their Hold Rating on Bravura Solutions Limited (BVS)

TIPRANKS
·
40 mins ago

Barrington Initiates Bioventus at Outperform With $13 Price Target

MT Newswires Live
·
Yesterday

Bioventus (BVS) Has a New Rating from Barrington

TIPRANKS
·
Yesterday

Bioventus Initiated at Outperform by Barrington Research

Dow Jones
·
Yesterday

Bioventus Inc : Barrington Research Initiates Coverage With Outperform Rating; Price Target $13

THOMSON REUTERS
·
Yesterday

Bravura Solutions Lifts FY26 Guidance on Strong Project Activity

TIPRANKS
·
Yesterday

The Market Doesn't Like What It Sees From Bravura Solutions Limited's (ASX:BVS) Revenues Yet As Shares Tumble 29%

Simply Wall St.
·
Feb 05

Bravura Solutions Limited (BVS) Receives a Hold from Canaccord Genuity

TIPRANKS
·
Jan 31

Is Bravura Solutions Limited (ASX:BVS) Trading At A 31% Discount?

Simply Wall St.
·
Jan 20

Bravura Sets 11 February Date for Half-Year 2026 Results Briefing

TIPRANKS
·
Jan 15

Bravura Solutions to Issue 835,645 Unquoted Employee Rights Under Incentive Plan

TIPRANKS
·
Jan 12

Bravura Solutions Cancels Employee and Performance Rights

TIPRANKS
·
Jan 12

Bravura Solutions Issues Notice on Conversion of Unquoted Equity Securities

TIPRANKS
·
Jan 12

Bravura Solutions (ASX:BVS) jumps 6.7% this week, though earnings growth is still tracking behind three-year shareholder returns

Simply Wall St.
·
Dec 10, 2025

Bioventus Director Guy P. Nohra Reports Sale of Common Shares

Reuters
·
Dec 09, 2025

Bioventus Inc. highlights market leadership and growth strategy in healthcare presentation

Reuters
·
Dec 03, 2025

Bioventus Inc. Files Initial Beneficial Ownership Statement for Director Ajay Dhankhar

Reuters
·
Nov 26, 2025

Bioventus CEO to Present at Piper Sandler Healthcare Conference

Reuters
·
Nov 26, 2025

Bravura Solutions Director Acquires Additional Shares

TIPRANKS
·
Nov 20, 2025

Bioventus Appoints Ajay Dhankhar to Board of Directors

Reuters
·
Nov 18, 2025